(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)heptanoic acid, 97%, 5g

O-(2-Fluorobenzyl)hydroxylamine hydrochloride, 98.0%, 5g

(S)-3-N-Boc-aminomethylpyrrolidine hydrochloride, 95.0%, 1g

tert-butyl 3-bromo-2H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carboxylate, 97%, 5g

Methyl 5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylate hydrochloride, 97%, 1g

5-(difluoromethyl)-1H-pyrazole-4-carboxylic acid, 97%, 10g

2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 95.0%, 100mg

3-(Methoxymethyl)-3-methylpiperidine hydrochloride, 97%, 100mg

2,6-Dimethylbenzothiazole>98.0%(GC)5g

Pipette distributrice Acura® 865, 100 à 1000 µl, 1 pièce

5-Bromo-2-iodoisonicotinaldehyde, 97%, 5g

2-Bromo-1-(3,4-difluoro-2-hydroxyphenyl)ethan-1-one, 95.0%, 250mg

[3-(Hydroxymethyl)pyridin-2-yl]methanol hydrochloride, 97%, 250mg